Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice. 2017

Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591.

Inactivating mutations in the insulin receptor results in extreme insulin resistance. The resulting hyperglycemia is very difficult to treat, and patients are at risk for early morbidity and mortality from complications of diabetes. We used the insulin receptor antagonist S961 to induce severe insulin resistance, hyperglycemia, and ketonemia in mice. Using this model, we show that glucagon receptor (GCGR) inhibition with a monoclonal antibody normalized blood glucose and β-hydroxybutyrate levels. Insulin receptor antagonism increased pancreatic β-cell mass threefold. Normalization of blood glucose levels with GCGR-blocking antibody unexpectedly doubled β-cell mass relative to that observed with S961 alone and 5.8-fold over control. GCGR antibody blockage expanded α-cell mass 5.7-fold, and S961 had no additional effects. Collectively, these data show that GCGR antibody inhibition represents a potential therapeutic option for treatment of patients with extreme insulin-resistance syndromes.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D007662 Ketosis A condition characterized by an abnormally elevated concentration of KETONE BODIES in the blood (acetonemia) or urine (acetonuria). It is a sign of DIABETES COMPLICATION, starvation, alcoholism or a mitochondrial metabolic disturbance (e.g., MAPLE SYRUP URINE DISEASE). Ketoacidosis,Metabolic Ketoacidosis,Metabolic Ketosis,Acetonemia,Acetonuria,Ketoacidemia,Ketoaciduria,Ketonemia,Ketonuria,Acetonemias,Acetonurias,Ketoacidemias,Ketoacidoses,Ketoacidoses, Metabolic,Ketoacidosis, Metabolic,Ketoacidurias,Ketonemias,Ketonurias,Ketoses, Metabolic,Ketosis, Metabolic,Metabolic Ketoacidoses,Metabolic Ketoses
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
September 2013, European journal of pharmacology,
Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
April 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
March 2016, The Journal of endocrinology,
Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
January 2019, American journal of physiology. Regulatory, integrative and comparative physiology,
Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
August 2002, Proceedings of the National Academy of Sciences of the United States of America,
Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
August 2016, Molecular metabolism,
Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
October 2022, Diabetes,
Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
April 2019, American journal of physiology. Endocrinology and metabolism,
Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
February 2003, Proceedings of the National Academy of Sciences of the United States of America,
Haruka Okamoto, and Katie Cavino, and Erqian Na, and Elizabeth Krumm, and Sun Y Kim, and Xiping Cheng, and Andrew J Murphy, and George D Yancopoulos, and Jesper Gromada
February 2014, Acta physiologica (Oxford, England),
Copied contents to your clipboard!